Systolic hypertension in adult nigerians with hypertension

Journal of the College of Physicians and Surgeons Pakistan

Volumn 17, Issue 1, 2007, Pages 8-11

  Opadijo, O G ^a   Salami, T A T ^a   Sanya, E O ^a   Omotoso, A B O ^a  

^a UNIVERSITY OF ILORIN   (Nigeria)

Author keywords

Age; Diastolic; Hypertension; Systolic; Target organ damage

Indexed keywords

CHOLESTEROL; CREATININE; GLUCOSE; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE CLASSIFICATION; FEMALE; GLUCOSE BLOOD LEVEL; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HIGH RISK POPULATION; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NIGERIA; OBSERVATIONAL STUDY; PREVALENCE; SPHYGMOMANOMETER; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; TARGET ORGAN; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NIGERIA; SYSTOLE;

EID: 34247367979     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Brown MJ. Haydock S. Pathoaetiology, epidemiology and diagnosis of hypertension. Drugs 2000; 59 (suppl 2): 1-12.
2. Opadiji OG. Risk factors associated with cardiovascular disease and death in adult Nigerians with essential hypertension. Nig J Int Med 2000; 3: 41-5.
3. The National Expert Committee on Non-Communicable Disease in Nigeria; a report of a national survey. 1992; 40: 12-15.
4. 1999 World Health Oganization - International Society of Hypertension. Guidelines for the management of hypertension. Guidelines subcommittee. J Hypertens 1999; 17: 151-83.
5. Collins R, Peto R, Macmanhon S, Herbert P, Fiebach NH, Eberten KA, et al. Blood pressure, stroke and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990: 335: 827-39.
6. Collins R, MachMahon S. Blood pressure, anti hypertensive drug treatment and the risks of stroke and coronary heart disease. Br Med Bull 1994; 50: 272-98.
7. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG. Birkenhager WH, et al. Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The systolic hypertension in Europe (Syst-Eur) trial investigations. Lancet 1997; 350: 757-64.
8. Galarza CR, Alfie J, Waisman GD, Mayorga LM, Camera LA, del Rio M, et al. Diastolic pressure underestimates age-related haemodynamic impairment. Hypertension 1997; 30: 809-16.
9. Mckee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971; 285: 1441-6.
10. National Kidney Foundation (K/DOQI). Clinical practice guidelines for chronic kidney disease evaluation, classification and stratification. Am J Kidney Dis 2002; 39 (suppl) 1: S I-S 266.
11. Alpert JS, Thygesen K, Antman E, Bassand JP, Myocardial infarction re-defined; a consensus document of the Joint European Society of Card iology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959-69.
12. Zachariah MG, Thankappar KR, Alex SC, Sarma PS, Vasan RS. Prevalence, correlates, awareness, treatment and control of hypertension in a middle-aged urban population in Kerala. Indian Heart J 2003; 55: 245-51.
13. Safdar S, Omar A, Faisal U, Hassan H. Prevalence of hypertension in a low income settlement of Karachi; Pakistan. J Pak Med Assoc 2004; 54: 506-9.
14. Chaudhry SI, Krumbolz HM, Foody JM. Systolic hypertension in older persons. JAMA 2004; 292: 1074-80.
15. Aziz K, Faruqui AM, Teri M, Davis CE, Abenathy J. Blood pressure and hypertension distribution in a low middle class urban community in Pakistan. J Pak Med Assoc 2005; 55: 333-8.
16. National High Blood Pressure Education Program Working Group. Report on hypertension in the elderly. Hypertension 1994; 23: 275-5.
17. Katibi IA, Adenle AD. Prevalence of electrocadiographic evidence of left ventricular hypertrophy among hypertensive Nigerians. Nig Med J 2002; 44: 7-9.
18. Araoye MA, Omotoso AB, Opadijo GO. The orthogonal and 12-lead ECG in adult negroes with systemic hypertension: comparison with age-matched control. West Afr J Med 1998; 17: 157-64.
19. Bundle branch block, hemiblocks and trifascicular blocks. In: Marriot HJL. Practical electrocardiography. 7th ed. Philadelphia: Williams & Wilkins 1983: 62-97.
20. Omotoso AB, Opadijo GO, Araoye MA. Intraventricular condition blocks in adult Nigerians with hypertensive heart diseases. Trop Cardiol 1999; 25: 75-9.
21. Kannel WB. Risk stratification in hypertension: new insights from the Framingham study. Am J Hypertens 2000; 13 (1 pt 2): 3S-10S.
22. Omotoso AB, Opadijo GO, Araoye MA. Arrhythmias in hypertensive heart disease: a study of 2,017 Nigerian patients. Niger Q J Hosp Med 1997; 7: 310-13.
23. Perry HM Jr, Miller JP, Fornoff JR, Baty JD, Sambhi MP, Rutan G, et al. Early predictions of 15 years end-stage renal disease in hypertensive patients. Hypertension 1995; 25 (4 pt 1): 587-94.
24. Akinsola A, Sanusi AA, Adelekun TA, Arogundade FA. The magnitude of the problem of chronic renal failure in Nigerians. AF J Nephrol 2004; 8: 24-6.
25. Akatsu H, Aslam A. Prevalence of hypertension and obesity among women over age 25 in a low income area in Karachi; Pakistan. J Pak Med Assoc 1996; 46: 191-3.
26. ALLHAT Officer and Coordinators for the ALLHAT Collaborative Research Group. The anti hype rten sive and lipid-lowering Treatment to prevent heart attack trail. Major outcome in high-risk hypertensive patients randomized to angiotensim-converting enzyme inhibitor or calcium channel blockers vs diuretic. The antihypertensive and lipid-lowering treatment to prevent heart Attack trial (ALLHAT). JAMA 2002; 288: 2981-97.
27. Galarza CR, Affie J, Waisman GD, Mayorga LM, Camera LA, del Rio M, et al. Diastolic pressure underestimates age-related hemodynamic impairment. Hypertension 1997; 30: 809-16.